|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 3242 for Thy1

<< First    < Previous  |  Next >    Last >>
0.063s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Gene
key_980125 | Thy1
Type: gene
Organism: Not Specified
•
•
•
•
•
Gene
7070 | THY1
Type: gene
Organism: human
•
•
•
•
•
Gene
100101744 | thy1
Type: gene
Organism: frog, western clawed
•
•
•
•
•
Gene
24832 | Thy1
Type: gene
Organism: rat
•
•
•
•
•
Gene
489365 | THY1
Type: gene
Organism: dog, domestic
•
•
•
•
•
Gene
451611 | THY1
Type: gene
Organism: chimpanzee
•
•
•
•
•
Gene
614712 | THY1
Type: gene
Organism: cattle
•
•
•
•
•
Gene
378897 | THY1
Type: gene
Organism: chicken
•
•
•
•
•
Gene
336617 | thy1
Type: gene
Organism: zebrafish
•
•
•
•
•
Gene
705321 | THY1
Type: gene
Organism: macaque, rhesus
•
•
•
•
•
Protein Domain
IPR033292 | THY1
Type: Family
Description: Thy-1 membrane glycoprotein (also known as CD90) was identified as an activation-associated cell adhesion molecule on human dermal microvascular endothelial cells. Its cellular effects vary; however, it most often seems to affect cell-cell or cell-matrix interactions and cellular adhesion and migration [, ]. Thy-1 interacts with the leukocyte integrin Mac-1 and may play an important role in the regulation of leukocyte recruitment to sites of inflammation []. It also plays an important role in normal retinal development [].
•
•
•
•
•
Protein Coding Gene
MGI:98747 | Thy1
Type: protein_coding_gene
Organism: mouse, laboratory
•
•
•
•
•
Publication
10567740 | J:58593
First Author: Simon PD
Year: 1999
Journal: Brain Res Dev Brain Res
Title: Thy-1 is critical for normal retinal development.
Volume: 117
Issue: 2
Pages: 219-23
•
•
•
•
•
Gene
117134602 | THY1-AS1
Type: gene
Organism: human
•
•
•
•
•
Publication
25416548 | J:219643
First Author: Woeller CF
Year: 2015
Journal: FASEB J
Title: Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.
Volume: 29
Issue: 3
Pages: 920-31
•
•
•
•
•
Publication
29401595 | J:272236
First Author: Paine A
Year: 2018
Journal: FASEB J
Title: Thy1 is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice.
Volume: 32
Issue: 6
Pages: 3174-3183
•
•
•
•
•
Publication
27767183 | J:242649
 
First Author: McCullough KM
Year: 2016
Journal: Nat Commun
Title: Molecular characterization of Thy1 expressing fear-inhibiting neurons within the basolateral amygdala.
Volume: 7
Pages: 13149
•
•
•
•
•
Publication
18676775 | J:157436
First Author: Cohen PY
Year: 2009
Journal: Am J Respir Cell Mol Biol
Title: Thy1 up-regulates FasL expression in lung myofibroblasts via Src family kinases.
Volume: 40
Issue: 2
Pages: 231-8
•
•
•
•
•
Publication
35941116 | J:327274
First Author: Koren E
Year: 2022
Journal: Nat Commun
Title: Thy1 marks a distinct population of slow-cycling stem cells in the mouse epidermis.
Volume: 13
Issue: 1
Pages: 4628
•
•
•
•
•
Protein
P01831
Organism: Mus musculus/domesticus
Length: 162  
Fragment?: false
•
•
•
•
•
Protein
Q53YX2
Organism: Mus musculus/domesticus
Length: 162  
Fragment?: false
•
•
•
•
•
Protein
A0A1L1SUX8
Organism: Mus musculus/domesticus
Length: 125  
Fragment?: true
•
•
•
•
•
Publication
15004192 | -
First Author: Wetzel A
Year: 2004
Journal: J Immunol
Title: Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).
Volume: 172
Issue: 6
Pages: 3850-9
•
•
•
•
•
Publication
25300130 | -
 
First Author: Leyton L
Year: 2014
Journal: Adv Neurobiol
Title: Thy-1 modulates neurological cell-cell and cell-matrix interactions through multiple molecular interactions.
Volume: 8
Pages: 3-20
•
•
•
•
•
Publication
15093746 | -
First Author: Barker TH
Year: 2004
Journal: Exp Cell Res
Title: Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity.
Volume: 295
Issue: 2
Pages: 488-96
•
•
•
•
•
Publication
21228213 | J:173721
First Author: Itami S
Year: 2011
Journal: Biol Reprod
Title: The roles of THY1 and integrin beta3 in cell adhesion during theca cell layer formation and the effect of follicle-stimulating hormone on THY1 and integrin beta3 localization in mouse ovarian follicles.
Volume: 84
Issue: 5
Pages: 986-95
•
•
•
•
•
Publication
30287384 | J:295671
 
First Author: Gilman TL
Year: 2018
Journal: Neurobiol Learn Mem
Title: Basolateral amygdala Thy1-expressing neurons facilitate the inhibition of contextual fear during consolidation, reconsolidation, and extinction.
Volume: 155
Pages: 498-507
•
•
•
•
•
Publication
16384609 | J:129236
First Author: Chen SJ
Year: 2006
Journal: Immunol Lett
Title: Kinetics of adaptive immunity to Haemophilus influenzae type b meningitis in transgenic mice: evidence from diverse expression of double T1/T2 transgenes and Th1/Th2-related cytokines.
Volume: 105
Issue: 1
Pages: 6-15
•
•
•
•
•
Publication
36066980 | J:331797
 
First Author: Marangoni RG
Year: 2022
Journal: JCI Insight
Title: Thy-1 plays a pathogenic role and is a potential biomarker for skin fibrosis in scleroderma.
Volume: 7
Issue: 19
•
•
•
•
•
Publication
39903666 | J:386362
First Author: Mix MR
Year: 2025
Journal: Cell Rep
Title: Repetitive antigen stimulation in the periphery dictates the composition and recall responses of brain-resident memory CD8(+) T??cells.
Volume: 44
Issue: 2
Pages: 115247
•
•
•
•
•
Publication
37468506 | J:378287
First Author: Pritzl CJ
Year: 2023
Journal: Nat Commun
Title: IKK2/NFkB signaling controls lung resident CD8(+) T cell memory during influenza infection.
Volume: 14
Issue: 1
Pages: 4331
•
•
•
•
•
Publication
39368486 | J:358144
First Author: Messmer JM
Year: 2024
Journal: Immunity
Title: T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels.
Volume: 57
Issue: 11
Pages: 2688-2703.e11
•
•
•
•
•
Publication
27521269 | J:258955
First Author: Schietinger A
Year: 2016
Journal: Immunity
Title: Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis.
Volume: 45
Issue: 2
Pages: 389-401
•
•
•
•
•
Publication
18354198 | J:133382
First Author: Voehringer D
Year: 2008
Journal: J Immunol
Title: Homeostasis and effector function of lymphopenia-induced "memory-like" T cells in constitutively T cell-depleted mice.
Volume: 180
Issue: 7
Pages: 4742-53
•
•
•
•
•
Publication
22124658 | J:180817
First Author: W?thrich M
Year: 2012
Journal: Infect Immun
Title: Limited model antigen expression by transgenic fungi induces disparate fates during differentiation of adoptively transferred T cell receptor transgenic CD4+ T cells: robust activation and proliferation with weak effector function during recall.
Volume: 80
Issue: 2
Pages: 787-97
•
•
•
•
•
Publication
32750334 | J:370603
First Author: Effern M
Year: 2020
Journal: Immunity
Title: Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma.
Volume: 53
Issue: 3
Pages: 564-580.e9
•
•
•
•
•
Publication
40199327 | J:370009
First Author: Mortazavi Farsani SS
Year: 2025
Journal: Cell Metab
Title: Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy.
Volume: 37
Issue: 6
Pages: 1294-1310.e7
•
•
•
•
•
Publication
39572569 | J:371366
First Author: Yang W
Year: 2024
Journal: Nat Commun
Title: Calcium nanoparticles target and activate T cells to enhance anti-tumor function.
Volume: 15
Issue: 1
Pages: 10095
•
•
•
•
•
Publication
36220073 | J:355257
First Author: Tcyganov EN
Year: 2022
Journal: Cancer Cell
Title: Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy.
Volume: 40
Issue: 10
Pages: 1173-1189.e6
•
•
•
•
•
Publication
41857410 | J:385417
First Author: Basak D
Year: 2026
Journal: EMBO Rep
Title: S1P-S1PR1 signaling impairs CD8(+) T cell metabolism and effector function in tumors.
Volume: 27
Issue: 8
Pages: 2000-2028
•
•
•
•
•
Publication
32464150 | J:300330
First Author: Azzolino V
Year: 2021
Journal: J Invest Dermatol
Title: Jak Inhibitors Reverse Vitiligo in Mice but Do Not Deplete Skin Resident Memory T Cells.
Volume: 141
Issue: 1
Pages: 182-184.e1
•
•
•
•
•
Publication
40258951 | J:371152
First Author: Wang Y
Year: 2025
Journal: Nat Cell Biol
Title: Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function.
Volume: 27
Issue: 5
Pages: 835-846
•
•
•
•
•
Publication
41521424 | J:392143
First Author: Morgado-C??ceres P
Year: 2026
Journal: Oncoimmunology
Title: DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 (+) T cell responses and therapeutic protection in mouse tumor models.
Volume: 15
Issue: 1
Pages: 2606497
•
•
•
•
•
Publication
39999838 | J:364153
First Author: Zhou X
Year: 2025
Journal: Cell Rep Med
Title: Potentiating anti-tumor immunity by re-engaging immune synapse molecules.
Volume: 6
Issue: 3
Pages: 101975
•
•
•
•
•
Publication
40287947 | J:386354
First Author: Srivastava J
Year: 2025
Journal: Cancer Res
Title: Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors.
Volume: 85
Issue: 12
Pages: 2268-2287
•
•
•
•
•
Publication
41812067 | J:389460
First Author: Magno JC
Year: 2026
Journal: Cancer Res
Title: Engineering T Cells with a Tumor-Reactive Chimeric T-cell Receptor Reduces Exhaustion and Promotes Persistence to Elicit Enhanced Antitumor Responses.
Volume: 86
Issue: 11
Pages: 2688-2702
•
•
•
•
•
Publication
40897177 | J:376876
First Author: Zhang FQ
Year: 2025
Journal: Cell Rep Med
Title: Zeaxanthin augments CD8(+) effector T cell function and immunotherapy efficacy.
Volume: 6
Issue: 9
Pages: 102324
•
•
•
•
•
Publication
42440549 | J:389515
 
First Author: Gellert S
Year: 2026
Journal: Front Immunol
Title: Oncolytic virotherapy counteracts the selection of IFN-unresponsive cancer cells post-immunotherapy but is limited by the emergence of dedifferentiated cancer cells.
Volume: 17
Pages: 1875225
•
•
•
•
•
Publication
35059651 | J:371089
First Author: Effern M
Year: 2022
Journal: STAR Protoc
Title: CRISPitope: A generic platform to model target antigens for adoptive T?cell transfer therapy in mouse tumor models.
Volume: 3
Issue: 1
Pages: 101038
•
•
•
•
•
Publication
40590857 | J:387273
First Author: Hammons JN
Year: 2026
Journal: Hepatology
Title: Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma.
Volume: 84
Issue: 1
Pages: 20-36
•
•
•
•
•
Publication
30970254 | J:300299
First Author: Misumi I
Year: 2019
Journal: Cell Rep
Title: Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection.
Volume: 27
Issue: 2
Pages: 514-524.e5
•
•
•
•
•
Publication
- | J:30773
 
First Author: Zaleski MB
Year: 1975
Journal: Immunogenetics
Title: Immune response of mice to the Thy-1.1 antigen: effect of the Ir-5 alleles studies in 129/J and B10.129(6M) mice.
Volume: 2
Pages: 241-8
•
•
•
•
•
Publication
15763918 | J:128250
First Author: Ranheim EA
Year: 2004
Journal: Autoimmunity
Title: Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
Volume: 37
Issue: 8
Pages: 555-67
•
•
•
•
•
Publication
39362791 | J:389122
 
First Author: Detr??s Rom??n CR
Year: 2024
Journal: J Immunother Cancer
Title: Vaccination generates functional progenitor tumor-specific CD8 T cells and long-term tumor control.
Volume: 12
Issue: 10
•
•
•
•
•
Publication
41100192 | J:382773
 
First Author: Ren Y
Year: 2026
Journal: J Immunol
Title: eEF2K promotes immune evasion in melanoma via Cyclin D1-mediated stabilization of PD-L1.
Volume: 215
Issue: 2
•
•
•
•
•
Publication
4108877 | J:5243
 
First Author: Raff MC
Year: 1971
Journal: Transplant Rev
Title: Surface antigenic markers for distinguishing T and B lymphocytes in mice.
Volume: 6
Pages: 52-80
•
•
•
•
•
Publication
10102300 | J:55613
First Author: Li Y
Year: 1999
Journal: Invest Ophthalmol Vis Sci
Title: Experimental induction of retinal ganglion cell death in adult mice.
Volume: 40
Issue: 5
Pages: 1004-8
•
•
•
•
•
Publication
38897196 | J:352545
First Author: Andreata F
Year: 2024
Journal: Cell
Title: Therapeutic potential of co-signaling receptor modulation in hepatitis B.
Volume: 187
Issue: 15
Pages: 4078-4094.e21
•
•
•
•
•
Publication
34912121 | J:338087
First Author: Xu Z
Year: 2022
Journal: Nature
Title: Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
Volume: 601
Issue: 7891
Pages: 118-124
•
•
•
•
•
Publication
40815646 | J:373358
First Author: Zhang R
Year: 2025
Journal: Sci Adv
Title: USP30 inhibition augments mitophagy to prevent T cell exhaustion.
Volume: 11
Issue: 33
Pages: eadv6902
•
•
•
•
•
Publication
28216674 | J:275116
 
First Author: Clarkson BD
Year: 2017
Journal: Sci Rep
Title: CCR7 deficient inflammatory Dendritic Cells are retained in the Central Nervous System.
Volume: 7
Pages: 42856
•
•
•
•
•
Publication
25063868 | J:273489
First Author: Huang W
Year: 2014
Journal: J Immunol
Title: IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function.
Volume: 193
Issue: 5
Pages: 2267-72
•
•
•
•
•
Publication
23562810 | J:202569
First Author: Lee SY
Year: 2013
Journal: J Immunol
Title: The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.
Volume: 190
Issue: 10
Pages: 4991-9
•
•
•
•
•
Publication
37418548 | J:364483
First Author: Zimmermannova O
Year: 2023
Journal: Sci Immunol
Title: Restoring tumor immunogenicity with dendritic cell reprogramming.
Volume: 8
Issue: 85
Pages: eadd4817
•
•
•
•
•
Publication
39648330 | J:385833
First Author: Ando Y
Year: 2025
Journal: Oncoimmunology
Title: Hyperdifferentiated murine melanoma cells promote adaptive anti-tumor immunity but activate the immune checkpoint system.
Volume: 14
Issue: 1
Pages: 2437211
•
•
•
•
•
Publication
30138536 | J:266480
First Author: Choi BK
Year: 2018
Journal: Eur J Immunol
Title: RELT negatively regulates the early phase of the T-cell response in mice.
Volume: 48
Issue: 10
Pages: 1739-1749
•
•
•
•
•
Publication
33037893 | J:371025
First Author: Hernandez R
Year: 2021
Journal: Cancer Immunol Immunother
Title: Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8(+) T cells to enhance antitumor immunity.
Volume: 70
Issue: 4
Pages: 909-921
•
•
•
•
•
Publication
19843938 | J:156799
First Author: Wang L
Year: 2009
Journal: J Immunol
Title: Epidermal Langerhans cells are not required for UV-induced immunosuppression.
Volume: 183
Issue: 9
Pages: 5548-53
•
•
•
•
•
Publication
4606643 | J:5487
First Author: Zaleski M
Year: 1974
Journal: J Immunol
Title: Immune response of mice to Thy-1. 1 antigen: genetic control by alleles at the Ir-5 locus loosely linked to the H-2 complex.
Volume: 113
Issue: 4
Pages: 1170-7
•
•
•
•
•
Publication
30605681 | J:354686
First Author: Jayant K
Year: 2019
Journal: Cell Rep
Title: Flexible Nanopipettes for Minimally Invasive Intracellular Electrophysiology In?Vivo.
Volume: 26
Issue: 1
Pages: 266-278.e5
•
•
•
•
•
Publication
40986642 | J:392205
First Author: Alamir H
Year: 2025
Journal: Sci Signal
Title: TIM3 is a context-dependent coregulator of cytotoxic T cell function.
Volume: 18
Issue: 905
Pages: eadk4594
•
•
•
•
•
Publication
37868095 | J:348911
First Author: Liu T
Year: 2023
Journal: Cell Insight
Title: Cannabinoid receptor 2 signal promotes type 2 immunity in the lung.
Volume: 2
Issue: 5
Pages: 100124
•
•
•
•
•
Publication
14207060 | J:24839
First Author: REIF AE
Year: 1964
Journal: J Exp Med
Title: THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.
Volume: 120
Issue: 3
Pages: 413-33
•
•
•
•
•
Publication
5919593 | J:5012
First Author: Reif AE
Year: 1966
Journal: Nature
Title: Mouse thymic iso-antigens.
Volume: 209
Issue: 5022
Pages: 521-3
•
•
•
•
•
Publication
16203866 | J:107466
First Author: Chen TT
Year: 2005
Journal: J Exp Med
Title: TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis.
Volume: 202
Issue: 7
Pages: 955-65
•
•
•
•
•
Publication
35091434 | J:392036
First Author: Booty MG
Year: 2022
Journal: J Immunol
Title: Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8(+) T Cell Responses with Antitumor Activity.
Volume: 208
Issue: 4
Pages: 929-940
•
•
•
•
•
Publication
37267916 | J:347552
First Author: Beziaud L
Year: 2023
Journal: Cell Stem Cell
Title: IFN?-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy.
Volume: 30
Issue: 6
Pages: 818-831.e6
•
•
•
•
•
Publication
16210634 | J:119110
First Author: W?thrich M
Year: 2005
Journal: J Immunol
Title: IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts.
Volume: 175
Issue: 8
Pages: 5288-97
•
•
•
•
•
Publication
37378557 | J:341132
First Author: Lee J
Year: 2023
Journal: Cancer Discov
Title: Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.
Volume: 13
Issue: 9
Pages: 2090-2105
•
•
•
•
•
Publication
42213780 | J:387483
First Author: Weng CH
Year: 2026
Journal: Cell Rep
Title: Tumor-intrinsic expression of signal regulatory protein ?? contributes to the suppression of anti-tumor immune responses.
Volume: 45
Issue: 6
Pages: 117443
•
•
•
•
•
Publication
41348132 | J:386340
First Author: Wittling MC
Year: 2026
Journal: Cancer Immunol Res
Title: T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy.
Volume: 14
Issue: 3
Pages: 463-477
•
•
•
•
•
Publication
33691090 | J:305972
First Author: Ma X
Year: 2021
Journal: Cell Metab
Title: CD36-mediated ferroptosis dampens intratumoral CD8(+) T?cell effector function and impairs their antitumor ability.
Volume: 33
Issue: 5
Pages: 1001-1012.e5
•
•
•
•
•
Publication
38271280 | J:365816
First Author: Sharma J
Year: 2024
Journal: J Leukoc Biol
Title: E3 ubiquitin ligase CBLB regulates innate immune responses and bacterial dissemination during nontuberculous mycobacteria infection.
Volume: 115
Issue: 6
Pages: 1118-1130
•
•
•
•
•
Publication
34716584 | J:370959
First Author: Borst L
Year: 2022
Journal: Int J Cancer
Title: NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
Volume: 150
Issue: 4
Pages: 688-704
•
•
•
•
•
Publication
37860697 | J:352699
First Author: Yan H
Year: 2023
Journal: iScience
Title: The transcription factor IRF4 determines the anti-tumor immunity of CD8(+) T?cells.
Volume: 26
Issue: 11
Pages: 108087
•
•
•
•
•
Publication
39153200 | J:353912
First Author: Ulibarri MR
Year: 2024
Journal: Cell Rep
Title: Epithelial organoid supports resident memory CD8 T?cell differentiation.
Volume: 43
Issue: 8
Pages: 114621
•
•
•
•
•
Publication
30971427 | J:280528
First Author: Chakraborty P
Year: 2019
Journal: J Biol Chem
Title: Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells.
Volume: 294
Issue: 23
Pages: 9198-9212
•
•
•
•
•
Publication
34525340 | J:370605
First Author: Molodtsov AK
Year: 2021
Journal: Immunity
Title: Resident memory CD8(+) T?cells in regional lymph nodes mediate immunity to metastatic melanoma.
Volume: 54
Issue: 9
Pages: 2117-2132.e7
•
•
•
•
•
Publication
- | J:4469
 
First Author: Snell GD
Year: 1971
Journal: Transplant Proc
Title: The histocompatibility systems
Volume: 3
Pages: 1133-1138
•
•
•
•
•
Publication
30651548 | J:270705
First Author: Hsu M
Year: 2019
Journal: Nat Commun
Title: Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells.
Volume: 10
Issue: 1
Pages: 229
•
•
•
•
•
Publication
36773294 | J:333452
First Author: Mandarano AH
Year: 2023
Journal: Cell Rep
Title: DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T?cell development.
Volume: 42
Issue: 2
Pages: 112106
•
•
•
•
•
Publication
25205101 | J:216686
First Author: Chatterjee S
Year: 2014
Journal: Cancer Res
Title: Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors.
Volume: 74
Issue: 21
Pages: 6048-59
•
•
•
•
•
Publication
23785152 | J:352204
First Author: Jasnow AM
Year: 2013
Journal: J Neurosci
Title: Thy1-expressing neurons in the basolateral amygdala may mediate fear inhibition.
Volume: 33
Issue: 25
Pages: 10396-404
•
•
•
•
•
Publication
23999499 | J:203429
First Author: Klebanoff CA
Year: 2013
Journal: J Exp Med
Title: Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells.
Volume: 210
Issue: 10
Pages: 1961-76
•
•
•
•
•
Publication
39546607 | J:359352
First Author: Oberholtzer N
Year: 2024
Journal: Sci Adv
Title: H(2)S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic response.
Volume: 10
Issue: 46
Pages: eadp1152
•
•
•
•
•
Publication
35614223 | J:345021
First Author: Badrinath S
Year: 2022
Journal: Nature
Title: A vaccine targeting resistant tumours by dual T cell plus NK cell attack.
Volume: 606
Issue: 7916
Pages: 992-998
•
•
•
•
•
Publication
20547866 | J:161365
First Author: Krieg C
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells.
Volume: 107
Issue: 26
Pages: 11906-11
•
•
•
•
•
Publication
23926324 | J:205788
First Author: Brinkman CC
Year: 2013
Journal: J Immunol
Title: Peripheral tissue homing receptors enable T cell entry into lymph nodes and affect the anatomical distribution of memory cells.
Volume: 191
Issue: 5
Pages: 2412-25
•
•
•
•
•
Publication
39745382 | J:385705
First Author: Torres-Mejia E
Year: 2025
Journal: Cancer Immunol Res
Title: Lung Cancer-Intrinsic SOX2 Expression Mediates Resistance to Checkpoint Blockade Therapy by Inducing Treg-Dependent CD8+ T-cell Exclusion.
Volume: 13
Issue: 4
Pages: 496-516
•
•
•
•
•
Publication
28542595 | J:337254
First Author: Nanjappa SG
Year: 2017
Journal: PLoS Pathog
Title: Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFN? cells.
Volume: 13
Issue: 5
Pages: e1006356
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom